MSA

Updates on the development of treatments for MSA 2:07
Updates on the development of treatments for MSA
Carlo Colosimo • 16 Sep 2022
Emerging neuromodulation techniques in Parkinson’s disease 2:22
Emerging neuromodulation techniques in Parkinson’s disease
Carlo Alberto Artusi • 16 Sep 2022
Novel a-syn PET tracer shows promise for diagnosis and monitoring in synucleinopathies 7:46
Novel a-syn PET tracer shows promise for diagnosis and monitoring in synucleinopathies
Francesca Capotosti • 2 Sep 2022
Future lines of research in synucleinopathies 1:23
Future lines of research in synucleinopathies
Elizabeth Coon • 1 Apr 2022
Neuropalliative care is an emerging subspecialty 2:15
Neuropalliative care is an emerging subspecialty
Robin Bessemer • 4 Apr 2022
Complex symptom burden in atypical parkinsonism 1:16
Complex symptom burden in atypical parkinsonism
Robin Bessemer • 4 Apr 2022
Following disease progression with clinical milestones in PSP and MSA 2:21
Following disease progression with clinical milestones in PSP and MSA
Robin Bessemer • 4 Apr 2022
The power of biomarkers: movement disorders 7:35
The power of biomarkers: movement disorders
James Rowe • 7 Sep 2020
Atypical Parkinsonisms: clinical overview & challenges 3:28
Atypical Parkinsonisms: clinical overview & challenges
Carlo Colosimo • 7 Sep 2020
The content of VJNeurology is intended for healthcare professionals